Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy

Patients Withdrawing Dupilumab Monotherapy for COVID-19–Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy / A. Chiricozzi, L. Di Nardo, M. Talamonti, M. Galluzzo, C. De Simone, G. Fabbrocini, A.V. Marzano, G. Girolomoni, A. Offidani, M.T. Rossi, L. Bianchi, A. Cristaudo, M.T. Fierro, L. Stingeni, G. Pellacani, G. Argenziano, A. Patrizi, P. Pigatto, M. Romanelli, P. Savoia, P. Rubegni, C. Foti, N. Milanesi, A. Belloni Fortina, M.R. Bongiorno, T. Grieco, S. Di Nuzzo, M.C. Fargnoli, A. Carugno, A. Motolese, F. Rongioletti, P. Amerio, R. Balestri, C. Potenza, G. Micali, C. Patruno, I. Zalaudek, M. Lombardo, C. Feliciani, F. Antonelli, S.M. Ferrucci, F. Guarneri, K. Peris. - In: DERMATITIS. - ISSN 1710-3568. - 33:3(2022 Jun), pp. e25-e29. [10.1097/DER.0000000000000814]